Order results by:
| Issue | Title | |
| Vol 1, No 2 (2005) | INFLUENCE OF MILDRONATE ON EFFICIENCY OF ANTIANGINAL THERAPY IN PATIENTS WITH STABLE BURDEN ANGINA | Abstract similar documents |
| N. P. Kutishenko, N. A. Dmitrieva, Y. V. Lukina, M. P. Kozireva, Y. E. Semyonova, A. D. Deev, S. Y. Martsevich | ||
| "... with M (p=0,002), and with Pl (p=0,02) was noted. With M treatment decrease in NTT treatment (p=0.02 ..." | ||
| Vol 14, No 5 (2018) | Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation | Abstract similar documents |
| M. H. Fedorova, V. L. Doshchitsin, A. V. Chapurnykh | ||
| "... Aim. Comparison of different treatment tactics – medicated antiarrhythmic therapy (AAT ..." | ||
| Vol 13, No 5 (2017) | IRON DEFICIENCY AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| N. I. Stuklov | ||
| "... В статье рассматриваются проблемы дефицита железа и анемии при хронической сердечной ..." | ||
| Vol 11, No 3 (2015) | EVALUATION OF THE REGULARITY OF ANTIHYPERTENSIVE DRUGS USAGE AS A COMPONENT OF TREATMENT ADHERENCE IN OUTPATIENTS OF A SPECIALIZED CARDIOLOGY CENTER | Abstract PDF (Eng) similar documents |
| A. V. Kontsevaya, T. S. Romanenko, V. A. Vygodin, S.B B. Fitilev | ||
| "... отдельных компонентов приверженности, включая регулярность приема препаратов, и причин несоблюдения ..." | ||
| Vol 8, No 3 (2012) | CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova | ||
| "... показателей ДФ, оценку толерантности к физической нагрузке (ТФН). Результаты. Длительные КФТ умеренной ..." | ||
| Vol 6, No 6 (2010) | NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya | ||
| "... in group A1 with type 2 and type 3 of LV remodeling reduced less (2%, p=0.02 and 4%, p=0.04, respectively ..." | ||
| Vol 4, No 3 (2008) | DYNAMICS OF THE HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION DURING ATORVASTATIN THERAPY | Abstract similar documents |
| E. S. Kozlova, E. E. Galaktionova, F. A. Nemchuk, Yu. M. Lopatin | ||
| "... % (р <0,02), total power (TP) of spectrum on 28% (р <0,03) and high frequency (HF) component on 53 % (р ..." | ||
| Vol 10, No 6 (2014) | THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER | Abstract similar documents |
| S. Y. Martsevich, A. R. Navasardyan, N. P. Kutishenko, A. V. Zakharova, V. P. Voronina, N. A. Dmitrieva, L. Yu. Lrozdova, A. V. Zagrebelnyy, O. V. Lerman, Yu. V. Lukina, G. V. Martynova, A. A. Nikulina, G. S. Ryazanova, A. Yu. Suvorov, S. N. Tolpygina | ||
| "... причинами отказа от приема НОАК стали удовлетворительный прием варфарина (32,6%), высокая цена данных ..." | ||
| Vol 17, No 1 (2021) | Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease | Abstract similar documents |
| O. A. Fomina, S. S. Yakushin | ||
| "... .7;15.0] vs 1.2 [0.1;7.7] ng/ml р=0.02) were identified in blood tests of MIOCA patients in the comparison ..." | ||
| Vol 17, No 4 (2021) | Obstructive sleep apnea and cardiovascular comorbidity: common pathophysiological mechanisms to cardiovascular disease | Abstract similar documents |
| M. V. Agaltsov, O. M. Drapkina | ||
| "... . Хотя в обзоре эти реакции рассматриваются раздельно, при развитии апноэ во сне они происходят ..." | ||
| Vol 16, No 6 (2020) | Healthy Diet: New Rations for Individual Use | Abstract similar documents |
| O. B. Shvabskaia, N. S. Karamnova, O. V. Izmailova | ||
| Vol 19, No 6 (2023) | Refusal of prescribed drug therapy (absolute non-adherence) after acute myocardial infarction/unstable angina: data from prospective observation in the LIS-3 registry | Abstract similar documents |
| S. Yu. Martsevich, N. P. Zolotareva, A. V. Zagrebelnyy, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, O. M. Drapkina | ||
| "... опроса (в среднем через 3 года после выписки) в живых осталось 226 больных. При опросе использовалась ..." | ||
| Vol 15, No 6 (2019) | Possibilities of PRECISE-DAPT Score for Risk Prediction of Ischemic and Hemorrhagic Events in ST-Elevated Myocardial Infarction (According to the Data of the Registry Study in Kemerovo) | Abstract similar documents |
| D. Yu. Sedykh, V. V. Kashtalap, R. M. Velieva, O. L. Barbarash | ||
| "... disease and polyvascular disease (р=0.002), prior angina pectoris (р=0.001), as well as the course ..." | ||
| Vol 13, No 1 (2017) | CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION | Abstract similar documents |
| V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova | ||
| "... .1%; p=0.02) after PCI in RT(–) group. Conclusion. The incidence of VT and SVT paroxysms, episodes ..." | ||
| Vol 14, No 6 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety | Abstract PDF (Eng) similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... safety criteria is [0,02-0,38] for QT prolongation and [-0,04-0,04] for bradycardia. Conclusion. Safety ..." | ||
| Vol 19, No 5 (2023) | Nephroprotective effect of atorvastatin at a dose of 80 mg in patients with ST-segment elevation myocardial infarction with an invasive treatment strategy | Abstract similar documents |
| A. D. Gavrilko, E. M. Mezhonov, S. V. Shalaev, D. V. Krasheninin | ||
| "... in the control group: 6 (7,0%) vs 1 in the main group (1,2%) (p=0,120, OR (95% CI) — 0,17 (0,02-1 ..." | ||
| Vol 20, No 6 (2024) | Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, A. V. Kapytski | ||
| "... .043); platelet distribution width (β=1.36, 95% CI: 0.22-2.51; p=0.02); creatinine (β=0.11, 95% CI: 0.011-0.21; p ..." | ||
| Vol 16, No 6 (2020) | TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part II. Assessment of the Quality of Therapy | Abstract similar documents |
| N. O. Vasyukova, N. P. Kutishenko, Yu. V. Lukina, O. I. Zvonareva, S. Yu. Martsevich | ||
| "... ratio [OR] 7.66, 95% confidence interval [CI] 2.5-22.6; p=0.006), statins (OR 5.12, 95%CI 1.8-14.5; p=0.002 ..." | ||
| Vol 20, No 4 (2024) | Comparison of the quality of logistic regression models and a classification tree in predicting hospital mortality in elderly patients with non-ST-elevation myocardial infarction | Abstract similar documents |
| K. G. Pereverzeva, S. S. Yakushin, N. N. Peregudova, M. V. Mishutina | ||
| "... cardiogenic shock (CS): odds ratio (OR) 47.55; 4.00-589.16; p=0.002; new-onset atrial fibrillation: OR 6.45; 1 ..." | ||
| Vol 8, No 5 (2012) | TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE | Abstract similar documents |
| M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn | ||
| "... and IgG levels to MRI-MRIV (p=0.02) revealed. Increase in titre of antibodies to β1-adrenoceptors ..." | ||
| Vol 6, No 4 (2010) | GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY | Abstract similar documents |
| Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev | ||
| Vol 6, No 3 (2010) | GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY | Abstract similar documents |
| Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen, M. O. Evseev | ||
| Vol 17, No 4 (2021) | Effect of Direct Oral Anticoagulants for Ulcer Epithelization and Laser Doppler Flowmetry Parameters In Patients with Diabetic Foot Syndrome and Atrial Fibrillation | Abstract similar documents |
| V. I. Petrov, N. V. Rogova, T. N. Кuzmina, A. S. Lishuta | ||
| "... parameters were found in both groups in both groups: an increase in the microcirculation index by 53.5% (p=0.02 ..." | ||
| Vol 14, No 2 (2018) | EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, Е. E. Shkolnikova, O. I. Lukina | ||
| "... .05), of the augmentation pressure (from 15.3Ѓ}8.9 to 10.5Ѓ}5.0 mm Hg, p=0.002), the increase in the reflected wave transit ..." | ||
| Vol 15, No 5 (2019) | Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure | Abstract similar documents |
| E. V. Kokhan, E. M. Ozova, V. A. Romanova, G. K. Kiyakbaev, Zh. D. Kobalava | ||
| "... [42;55]%; p=0.02) and E/E’(9.7 [7.8;12] vs 7.1 [5.6;8.6]; p=0.001) were worse than in men. Active LA ..." | ||
| Vol 6, No 6 (2010) | HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY | Abstract similar documents |
| V. V. Mazur, A. M. Kalinkin, E. S. Mazur | ||
| "... .06±0.02, 1.50±0.05 and 1.04±0.02, 1.37±0,06 and 1.00±0.01, respectively). Conclusion. The ESS LV/ESS ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva | ||
| "... of the treatment. In patients of Group 2 RI in MRA and arcuate IRA were increased from 0.67±0.06 to 0.69±0.06 (p=0.02 ..." | ||
| Vol 19, No 5 (2023) | Changes of myocardial dysfunction and injury biomarkers over chemotherapy for multiple myeloma: difficulties in laboratory data interpretation | Abstract similar documents |
| E. V. Fomina, S. A. Kardovskaya, D. A. Budanova, P. A. Markin, S. A. Appolonova, A. S. Lishuta, Yu. N. Belenkov, I. S. Ilgisonis | ||
| "... it accounted for 0,02 [0,01-0,68] and 0,65 [0,02; 1,51] ng/ml, respectively, with the normal range of less than ..." | ||
| Vol 6, No 6 (2010) | EFFICACY AND SAFETY OF SINUS RHYTHM RESTORATION WITH AMIODARONE AND PROPAFENONE IN OUTPATIENTS, ECONOMIC ASPECTS (BASED ON DATA OF N.A. SEMASHKO NORTHERN MEDICAL CLINICAL CENTER) | Abstract similar documents |
| T. A. Istomina, E. V. Serdechnaya, L. A. Kulminskaya, B. A. Tatarskiy, E. V. Kazakevich, V. L. Lipskiy, S. I. Martyushov | ||
| "... .029) and with propafenone — 4.5 h earlier (p=0.002) than that in hospital. The average dose of amiodarone in ambulatory ..." | ||
| Vol 5, No 6 (2009) | COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
| V. M. Provotorov, M. L. Gluhovsky | ||
| "... .0% of effectively treated patients vs 17.3%, p=0.02). Significant difference in a number of patients ceased therapy ..." | ||
| Vol 14, No 4 (2018) | Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing | Abstract similar documents |
| A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik | ||
| "... (interquartile range, IQR=7501 rubles) vs 1134 rubles (IQR=5911 rubles), respectively; p=0.02. Conclusion ..." | ||
| Vol 8, No 6 (2012) | RATIONAL PHARMACOTHERAPY IN TAKOTSUBO CARDIOMYOPATHY | Abstract similar documents |
| S. Marchev, T. Vekov | ||
| "... Рациональная фармакотерапия при кардиомиопатии Такоцубо основывается на клинической картине ..." | ||
| Vol 7, No 6 (2011) | ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS | Abstract similar documents |
| L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo | ||
| "... Цель. Анализ литературы и собственных данных о влиянии клопидогрела на тромбоциты при воспалении и ..." | ||
| Vol 8, No 1 (2012) | RANOLAZINE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. P. Lupanov | ||
| Vol 13, No 5 (2017) | RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM ROUTINE CONTROL TO EFFECTIVE MANAGEMENT | Abstract similar documents |
| N. А. Nikolayev, Y. P. Skirdenko, S. S. Bunova, A. V. Ershov | ||
| "... ; p=0.002 at the 150th week; p=0.004 at the 200th week). By the end of the study in the patient ..." | ||
| Vol 11, No 6 (2015) | Left ventricular remodeling in patients with right ventricular myocardial infarction | Abstract similar documents |
| M. T. Beyshenkulov,, Z. M. Chazymova, A. S. Abylgazieva, K. R. Kaliev | ||
| "... .54±0.02 to 0.59±0.03 units) and an increase in interventricular asynchrony (from 37.4±4.2 to 44.6±4 ..." | ||
| Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpigina | ||
| "... .4±5.0 (p=0.002) for all items of EF questionnaire and +0.67±2.3 (р<0.05) for the 1-5,15 items of EF ..." | ||
| Vol 21, No 1 (2025) | Correction of anemia using an iron supplement with a hepcidin-independent absorption mechanism in patients with chronic heart failure with preserved left ventricular ejection fraction | Abstract similar documents |
| A. A. Gurkina, N. I. Stuklov, V. A. Kokorin, R. R. Gimadiev, N. V. Varekha | ||
| "... status assessment scale (CAS), p = 0.01 and by the Minnesota Health Failure Questionnaire (MHFLQ), p = 0.002 ..." | ||
| Vol 12, No 3 (2016) | ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS | Abstract PDF (Eng) similar documents |
| R. A. Gajfulin, A. N. Sumin, O. G. Arhipov | ||
| "... correlated with age: At (p=0.004); Et/At (p=0.001); Vpt (p=0.002) and e't/a't ratio (p=0.004). Conclusion ..." | ||
| Vol 7, No 6 (2011) | DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL | Abstract similar documents |
| E. I. Tarlovskaya, D. A. Suvorova, A. A. Sobolev | ||
| "... systolic BP (BPs) more effectively than enalapril therapy did (18.2±5.4% vs 15.2±4.3%, р=0.02). In men ..." | ||
| Vol 11, No 4 (2015) | PILOT STUDY RESULTS OF THE INFLUENCE OF CITICOLINE AND PIRIBEDIL ON COGNITIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER CORONARY ARTERY BYPASS SURGERY | Abstract similar documents |
| M. M. Petrova, S. V. Prokopenko, O. V. Eremina, G. V. Matjushin, V. A. Sakovich, D. B. Drobot, E. Yu. Mozhejko, D. S. Kaskaeva | ||
| "... only in three tests: visual memory (immediate simulation; p=0.008), categorical association (p=0.002 ..." | ||
| Vol 12, No 6 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract PDF (Eng) similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... of bleeding was significantly lower with NOACs (RR=0.70; 95% CI 0.51-0.95; p=0.02). All-cause mortality rate ..." | ||
| Vol 12, No 1 (2016) | Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis | Abstract similar documents |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov | ||
| "... of bleeding was significantly lower with NOACs (RR=0.70; 95% CI 0.51-0.95; p=0.02). All-cause mortality rate ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... Equation significantly increases the accuracy of prediction of CHD (p=0.02 and p=0.010, respectively ..." | ||
| Vol 17, No 5 (2021) | Endothelial Microvascular Dysfunction and Its Relationship with Haptoglobin Levels in Patients with Different Phenotypes of Chronic Heart Failure | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, N. A. Dragomiretskaya, I. G. Beliaev, Ju. S. Kucherova, A. V. Kazadaeva | ||
| "... % confidence interval [CI] -0.256; -0.825, p=0.003) and HFrEF (r=-0.503, 95% CI -0.089; -0.803, p=0.02 ..." | ||
| Vol 18, No 3 (2022) | Assessment of the Quality of Drug Therapy in Patients with Stable Coronary Artery Disease in the Second Stage of the ALIGN Study | Abstract similar documents |
| E. D. Zharkova, S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, O. M. Drapkina | ||
| "... were studied in all patients. Results. An increase in the frequency of taking beta-blockers (p=0.002 ..." | ||
| Vol 16, No 4 (2020) | Changes in Arterial Wall Stiffness in Patients with Obesity and Paroxysmal Form of Atrial Fibrillation | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, K. K. Osadchiy, R. G. Gataulin, K. A. Oganesyan, N. V. Lobova, Z. B. Jafarova | ||
| "... index (r=0.443, p=0.003); between WC and CAVI index (r=0.493, p=0.002). A positive direct relationship ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... patients (p=0.35), high-risk patients (p<0.0001) and individuals who reached the target level of LDL-C (p=0.002 ..." | ||
| Vol 12, No 2 (2016) | CARDIORENAL INTERACTION IN DECOMPENSATED CHRONIC HEART FAILURE | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, M. A. Efremovtseva | ||
| Vol 12, No 5 (2016) | Pathogenic Mechanisms of Atrial Fibrillation in Obesity | Abstract similar documents |
| O. M. Drapkina, M. V. Nikolaeva | ||
| "... . Исследование патогенетических механизмов возникновения ФП при ожирении необходимо для разработки новых ..." | ||
| Vol 12, No 6 (2016) | THE PROGNOSIS IN TRANSCATHETER AORTIC VALVE IMPLANTATION | Abstract similar documents |
| T. E. Imaev, A. E. Komlev, R. S. Akchurin | ||
| "... почечной недостаточности. При анализе прогноза жизни больных, перенесших операцию ТИАК в раннем ..." | ||
| Vol 12, No 6 (2016) | THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| E. A. Smirnova, S. S. Yakushin | ||
| "... В статье обсуждаются вопросы выбора антикоагулянтов при различных вариантах течения острого ..." | ||
| Vol 8, No 5 (2012) | INFLAMMATORY REACTIONS IN EXPERIMENTAL MYOCARDIAL DAMAGE | Abstract similar documents |
| L. D. Khidirova, N. N. Mayanskaya | ||
| "... развитии воспалительных реакций при некоронарогенном повреждении миокарда в эксперименте. Материал и методы ..." | ||
| Vol 5, No 3 (2009) | ANTICOAGULANTS IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... Обсуждается клиническая эффективность нефракционированного и низкомолекулярных гепаринов при ..." | ||
| Vol 6, No 1 (2010) | SOME ASPECTS OF THE LISINOPRIL USAGE IN ARTERIAL HYPERTENSION TREATMENT | Abstract similar documents |
| N. A. Jaiani | ||
| "... , рассматриваются фармакоэкономические аспекты применения лизиноприла при артериальной гипертонии. ..." | ||
| Vol 13, No 3 (2017) | ACUTE ATORVASTATIN RECAPTURE THERAPY IN CORONARY ARTERY BYPASS GRAFTING | Abstract similar documents |
| A. V. Panov, M. L. Gordeev, A. A. Zhloba, T. F. Subbotina, I. V. Suhova, M. I. Buthashvili, I. T. Abesadze, M. Z. Alugishvili, N. L. Lohovinina, K. V. Korzhenevskaya, M. V. Solovyova, L. V. Mihaylova, E. S. Alekseevskaya | ||
| "... оксида азота и гомоцистеина в плазме крови у больных ишемической болезнью сердца при плановом коронарном ..." | ||
| Vol 9, No 3 (2013) | RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION | Abstract similar documents |
| V. A. Sulimov, A. V. Rodionov, A. A. Svetankova, I. E. Deneka | ||
| Vol 11, No 1 (2015) | ATRIAL FIBRILLATION ASSOCIATED WITH MYOCARDIAL INFARCTION OF DIFFERENT LOCALIZATIONS | Abstract similar documents |
| R. Bhattarai, S. A. Sayganov, E. V. Trofimova | ||
| "... локализации приступы ФП развивались в более поздние сроки, чем при нижнем ИМ (на 2-й день у 12 человек и у 11 ..." | ||
| Vol 3, No 1 (2007) | SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| Y. A. Vasyuk, K. G. Kulikov, O. N. Kudryakov, O. V. Krikunova, I. A. Sadulaeva | ||
| Vol 3, No 2 (2007) | IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, N. Kh. Khafizova, I. M. Karamova, A. N. Zakirova, R. G. Oganov | ||
| "... цитокинов – интерлейкина-4 и интерлейкина-10 (ИЛ-4, ИЛ-10). Результаты. При стенокардии II ФК установлен ..." | ||
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... эффективность препаратов магния при различных патологических состояниях системы кровообращения. Физиологическое ..." | ||
| Vol 3, No 5 (2007) | IMMUNO-INFLAMATORY RESPONSES IN ACUTE CORONARY SYNDROME | Abstract similar documents |
| R. G. Oganov, N. E. Zakirova, A. N. Zakirova, G. M. Salakhova, M. R. Plotnikova | ||
| "... . При НС и ОИМ выявлены гиперэкспрессия провоспалительных цитокинов ИЛ-1β, ИЛ-6, ФНО-α и повышенный ..." | ||
| Vol 5, No 1 (2009) | MYOCARDIAL REMODELING IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. N. Zakirova, R. G. Oganov, N. E. Zakirova, G. R. Klochkova, F. S. Musina | ||
| "... постинфарктного кардиосклероза развивается эксцентрическая гипертрофия ЛЖ. При этом отмечается нарушение ..." | ||
| Vol 17, No 1 (2021) | Cardiomyopathy of Friedreich's Disease. Modern Methods of Diagnostic | Abstract PDF (Eng) similar documents |
| E. I. Fomicheva, R. P. Myasnikov, Y. A. Selivyorstov, S. N. Illarioshkin, E. L. Dadali, O. M. Drapkina | ||
| Vol 4, No 3 (2008) | COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME | Abstract similar documents |
| E. I. Mananko, E. A. Bushkova, E. M. Idrisova, A. I. Vengerovsky | ||
| "... углеводный обмен, агрегацию тромбоцитов у больных артериальной гипертензией (АГ) при метаболическом синдроме ..." | ||
| Vol 4, No 3 (2008) | ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS | Abstract similar documents |
| V. A. Sulimov | ||
| "... возможности различных групп препаратов при выполнении чрескожных коронарных вмешательств с позиций ..." | ||
| Vol 4, No 4 (2008) | ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| N. E. Zakirova, R. G. Oganov, A. N. Zakirova, M. P. Plotnikova, G. M. Salakhova | ||
| "... и Е-селектина. Результаты. При стенокардии II ФК показатели ЭЗВД и ЭНЗВД, уровень ЭТ-1 и содержание ..." | ||
| Vol 19, No 1 (2023) | Arterial Hypertension and Severe COVID-19 in Hospitalized Patients: Data from a Cohort Study | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, L. V. Vasilyeva, E. S. Ogibenina, E. E. Bykova, I. I. Shvedov, A. A. Ivannikov, N. A. Druzhinina | ||
| "... having the strongest association (OR 1.595, 95% CI 1.178-2.158, p=0.002). Age, hypertension, glucose ..." | ||
| Vol 18, No 3 (2022) | Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease | Abstract similar documents |
| A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov | ||
| "... significant difference in the level of concentration of Phe and Tyr was revealed (p=0,002 and p=0 ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... and cardiovascular death risks: OR=0.38, р=0.01 and OR=0.25, р=0.02, respectively. Other drugs revealed ..." | ||
| Vol 20, No 1 (2024) | Clinical factors associated with the no/slow-reflow phenomenon in patients with acute coronary syndrome | Abstract similar documents |
| E. V. Konstantinova, Yu. S. Ilin, A. A. Velikotskiy, N. A. Rakhimi, A. A. Bogdanova, A. V. Ploshchenkov | ||
| "... .03; 95% CI: 0.95-0.996; p=0.02] and the proximal level of occlusion in infarct-related coronary artery ..." | ||
| Vol 8, No 2 (2012) | THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, M. L. Ginzburg, G. V. Matyushin, V. V. Skibitskiy, L. A. Sokolova, A. V. Deev | ||
| "... .08; for HR - 51 vs 53%, р=0.66; LDL cholesterol - 27.7 vs 9.9% of patients, p=0.002. There were ..." | ||
| Vol 20, No 5 (2024) | Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials | Abstract similar documents |
| E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev | ||
| "... embolism was 26% less likely to develop compared with warfarin (HR=0.74, 95% CI 0.57–0 .95, p=0.02 ..." | ||
| Vol 13, No 2 (2017) | POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER | Abstract similar documents |
| Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina | ||
| "... .9±3.9 cm; p=0.009), the left atrium volume (from 42.0±12.8 to 43.7±11.6 ml; p=0.02), the end diastolic ..." | ||
| Vol 17, No 3 (2021) | Causes, Predisposing Factors and Prevention Directions of Drug-induced Bradycardia (Based on the Results of the Hospital Register of Oardiac Medications Overdoses STORM) | Abstract similar documents |
| N. N. Nikulina, S. V. Seleznev, M. B. Chernysheva, S. S. Yаkushin | ||
| "... antagonists - 7.9% (decrease frequency over 5 years 4.0 times, p=0.002), other - 16.7%. In 56.8% of cases ..." | ||
| Vol 16, No 4 (2020) | Features of Structural and Functional Changes in the Heart in Elderly Patients with Coronary Heart Disease and Atrial Fibrillation | Abstract similar documents |
| L. I. Folomeeva, E. V. Filippov | ||
| "... in groups 2 and 3 – 27.2±0.1% and 27.9±0.1%, respectively, vs 36.3±0.1% and 38.20±0.02%, respectively ..." | ||
| Vol 17, No 3 (2021) | Chronic Heart Failure in Patients with Arterial Hypertension Associated with Obstructive Sleep Apnea Syndrome: Possible Options to Pathogenetic Therapy | Abstract similar documents |
| A. V. Yakovlev, S. N. Shilov, E. N. Berezikova, N. F. Yakovleva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, I. A. Efremov | ||
| "... .034) decreased by 34%, while in group 2, a significant (p = 0.002) increase in biomarker levels was revealed ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... .3±648.4 ng/ml, in group 2 - 2637.0±740.0 ng/ml (p=0.03) and in group 3 it was to 2632.1±666.0 ng/ml (p=0.002 ..." | ||
| Vol 9, No 6 (2013) | DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi | ||
| "... to 96.4±1.1ms (р=0.02) and reduction of LA anterior-posterior dimension up to 36.1±3.8 mm (р=0 ..." | ||
| Vol 15, No 2 (2019) | Current Predictors of Atrial Fibrillation Progression | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... was significantly higher and accounted for 59% as compared to 46% in the patients with hypertension (p=0.002) and 51 ..." | ||
| Vol 19, No 5 (2023) | Efficacy of azilsartan medoxomil in patients with hypertension and stable coronary artery disease in combination with type 2 diabetes | Abstract similar documents |
| A. M. Kochergina, O. L. Barbarash | ||
| "... ,35±6,59 vs 62,72±8,82 years (p=0,002). The mean BMI in women was higher and was 33.08 kg/m2, while ..." | ||
| Vol 20, No 1 (2024) | Clinical, electrical, and functional changes following CRT-P implantation: short-term results in patients with non-ischaemic cardiomyopathy | Abstract PDF (Eng) similar documents |
| S. A. Mostafa, A. М. Abdelmoneim, H. Ramadan, E. S. Elkeshk | ||
| "... there were statistically significant improvement in LVEDV (267.0±45.7 to 221.8±41.9 ml, p=0.002) and LVESV ..." | ||
| Vol 8, No 4 (2012) | RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS | similar documents |
| S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz | ||
| "... связь с увеличением образования циклического гуанозинмонофосфата в NO-стимулированных тромбоцитах (р<0,02 ..." | ||
| Vol 5, No 1 (2009) | CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. A. Anichkov, A. A. Platonova | ||
| "... , SD2, SD21) показатели. Результаты. Показатели ВСР, полученные при 24-часовых и 5-минутных записях ..." | ||
| Vol 18, No 2 (2022) | The Influence of Multivessel Bypass Surgery on the Onset of Atrial Fibrillation in Elderly Patients | Abstract similar documents |
| O. A. Rubanenko, A. O. Rubanenko | ||
| "... ) при одно- или двух- и более сосудистом шунтировании у пациентов с ишемической болезнью сердца пожилого ..." | ||
| Vol 18, No 2 (2022) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
| "... %] to 48 [80%], p=0.002). In group II, the number of patients with moderately reduced LVEF did ..." | ||
| Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
| A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
| "... (ARVI)/influenza was higher in the group without CVD – 28.3% vs 19.0% (p=0.02). The proportion of cases ..." | ||
| Vol 19, No 1 (2023) | Incidence and Severity of Acute Myocardial Injury after Thoracic Surgery: Effects of Nicorandil | Abstract similar documents |
| K. V. Protasov, O. A. Barahtenko, E. V. Batunova, E. A. Rasputina | ||
| "... concentration (all p<0.02 for related group differences). In the nicorandil group, in comparison ..." | ||
| Vol 15, No 5 (2019) | Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) | Abstract similar documents |
| E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... -blockers in CHF – 39% and 23.8% (p=0.002), respectively. During 4- year follow-up in the group ACVA+MI ..." | ||
| Vol 19, No 2 (2023) | Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization | Abstract similar documents |
| D. P. Golubovskaya, V. N. Karetnikova, A. B. Osokina, I. P. Oleinik, O. L. Barbarash | ||
| "... .01 and p=0.02). Complications, against the background of taking empagliflozin, were not noted: there were ..." | ||
| Vol 17, No 6 (2021) | Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina | ||
| "... diseases (20.1% and 15.3%; p=0.002). Patients with AF in the presence of CHF, compared with patients ..." | ||
| Vol 17, No 4 (2021) | Novel Biomarkers of Endothelial Dysfunction in Cardiovascular Diseases | Abstract similar documents |
| Z. M. Abdurakhmanov, B. Y. Umarov, M. M. Abdurakhmanov | ||
| "... может считаться более информативным и надежным клеточным маркером ЭД. Также авторами показано, что при ..." | ||
| Vol 18, No 4 (2022) | Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels | Abstract PDF (Eng) similar documents |
| O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov | ||
| "... SOFA, распространенности пневмонии при компьютерной томографии (КТ), органная дисфункция легких, почек ..." | ||
| Vol 12, No 3 (2016) | THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY | Abstract PDF (Eng) similar documents |
| T. Y. Gromyko, S. A. Sayganov | ||
| "... Цель. Оценить вероятность рецидивов фибрилляции предсердий (ФП) при различных вариантах ..." | ||
| Vol 5, No 2 (2009) | SECONDARY PULMONARY ARTERIAL HYPERTENSION IN SYSTEMIC DISEASES OF CONNECTIVE TISSUE | Abstract similar documents |
| N. A. Shostak, J. K. Novikov, A. L. Chernayev, A. A. Klimenko, P. V. Novikov | ||
| "... распространенности и встречаемости вторичной ЛАГ при системных заболеваниях соединительной ткани (СЗСТ), в том числе ..." | ||
| Vol 8, No 6 (2012) | HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| S. V. Moiseev | ||
| "... уступал ему по безопасности. Обсуждаются практические аспекты применения дабигатрана при ФП, в том числе ..." | ||
| Vol 5, No 3 (2009) | REPERFUSION THERAPY IN ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION | Abstract similar documents |
| A. L. Alyavi, B. A. Alyavi | ||
| "... (СТ) на параметры центральной и внутрисердечной гемодинамики при остром коронарном синдроме (ОКС) с ..." | ||
| Vol 7, No 1 (2011) | RESULTS OF TENEKTEPLASE USE IN MASSIVE PULMONARY THROMBOEMBOLISM. CLINICAL CASE | Abstract similar documents |
| R. Rajan, R. Natarajan, G. Vijayaraghavan | ||
| Vol 7, No 1 (2011) | ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS | Abstract similar documents |
| M. Yu. Gilyarov, V. A. Sulimov | ||
| 1 - 100 of 1252 Items | 1 2 3 4 5 6 7 8 9 10 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
